---
title: "Daunorubicin - Acute Myeloid Leukemia, Disease"
sidebar: mydoc_sidebar
permalink: db00694-mesh-d015470-1.html
toc: false 
---


Path ID: `DB00694_MESH_D015470_1`
{% include image.html url="images/db00694-mesh-d015470-1.png" file="db00694-mesh-d015470-1.png" alt="db00694-mesh-d015470-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D003630">MESH:D003630 </a> | daunorubicin | Drug |
| <a href="https://identifiers.org/GO:0001207">GO:0001207 </a> | histone displacement | BiologicalProcess |
| <a href="https://identifiers.org/GO:0009299">GO:0009299 </a> | mRNA transcription | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P11388">UniProt:P11388 </a> | DNA topoisomerase 2-alpha | Protein |
| <a href="https://identifiers.org/UniProt:Q02880">UniProt:Q02880 </a> | DNA topoisomerase 2-beta | Protein |
| <a href="https://identifiers.org/GO:0032993">GO:0032993 </a> | protein-DNA complex | CellularComponent |
| <a href="https://identifiers.org/MESH:D005609">MESH:D005609 </a> | Free Radicals | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D004249">MESH:D004249 </a> | DNA Damage | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006260">GO:0006260 </a> | DNA replication | BiologicalProcess |
| <a href="https://identifiers.org/HP:0031377">HP:0031377 </a> | Abnormal cell proliferation | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0006915">GO:0006915 </a> | apoptotic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0140014">GO:0140014 </a> | mitotic nuclear division | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015470">MESH:D015470 </a> | Acute myeloid leukemia, disease | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Daunorubicin | CONTRIBUTES TO | Histone Displacement |
| Histone Displacement | NEGATIVELY CORRELATED WITH | Mrna Transcription |
| Mrna Transcription | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Daunorubicin | NEGATIVELY REGULATES | Mitotic Nuclear Division |
| Mitotic Nuclear Division | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Daunorubicin | DECREASES ABUNDANCE OF | Protein-Dna Complex |
| Protein-Dna Complex | HAS PARTICIPANT | Dna Topoisomerase 2-Alpha |
| Protein-Dna Complex | HAS PARTICIPANT | Dna Topoisomerase 2-Beta |
| Dna Topoisomerase 2-Beta | POSITIVELY CORRELATED WITH | Dna Replication |
| Dna Topoisomerase 2-Alpha | POSITIVELY CORRELATED WITH | Dna Replication |
| Daunorubicin | INCREASES ABUNDANCE OF | Free Radicals |
| Free Radicals | POSITIVELY CORRELATED WITH | Dna Damage |
| Dna Damage | POSITIVELY CORRELATED WITH | Apoptotic Process |
| Apoptotic Process | NEGATIVELY CORRELATED WITH | Acute Myeloid Leukemia, Disease |
| Dna Replication | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Dna Replication | POSITIVELY CORRELATED WITH | Mitotic Nuclear Division |
| Mitotic Nuclear Division | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Abnormal Cell Proliferation | MANIFESTATION OF | Acute Myeloid Leukemia, Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00694](https://go.drugbank.com/drugs/DB00694)
  - [https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action](https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/)
